Myeloproliferative disease
BCR-JAK2 fusion as a result of a translocation (9;22)(p24;q11.2) in a patient with CML-like myeloproliferative disease
6
Conditional expression of oncogenic K ras from its endogenous promoter induces a myeloproliferative disease
12
PML RARA can increase hematopoietic self renewal without causing a myeloproliferative disease in mice
11
Normal hematopoiesis and neurofibromin deficient myeloproliferative disease require Erk
7
Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice
6
A retrovirus carrying the polyomavirus middle T gene induces acute thrombocythemic myeloproliferative disease in mice.
5
Platelet Fc Receptor: INCREASED EXPRESSION IN MYELOPROLIFERATIVE DISEASE
9
Pathogenesis and Mutations of Myeloproliferative Neoplasms: An Overview
24
The Role of MicroRNAs in Myeloproliferative Neoplasia
14
Transient suppression of clonal hemopoiesis associated with pregnancy in a patient with a myeloproliferative disorder
6
The JAK2V617F Mutation Seen in Myeloproliferative Neoplasms (MPNs) Occurs in Patients with Inflammatory Bowel Disease: Implications of a Pilot Study
6
Granulopoiesis in Chronic Myeloproliferative Disorders in Children
7
Neurological Complications of Myeloproliferative Syndromes with Negative Philadelphia Chromosome (MPS Ph-) in Lome Tertiary Hospital
5
SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms
7
Targeting the CALR interactome in myeloproliferative neoplasms
14
Incidence of myeloproliferative neoplasms in Calgary, Alberta, Canada
5
Pulmonary hypertension in patients with chronic myeloproliferative disorders
11
The epidemiology and clinical characteristics of myeloproliferative neoplasms in Malaysia
12
Molecular Defects in Chronic Myeloproliferative Disorders
13
Low-dose methotrexate in myeloproliferative neoplasm models
25